Latest News
World's First -- XellSmart's Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical Trial
SUZHOU, China, May 25, 2025 /PRNewswire/ -- In May 2025, XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy has received official approval from bothChina's N...
Industry Forums at 137th Canton Fair Spotlight Emerging Trends and Global Strategies
GUANGZHOU, China, May 25, 2025 /PRNewswire/ -- The 137th China Import and Export Fair (Canton Fair) hosted a series of high-level industry forums, bringing together government officials, financial institutions, business leaders, and subject matter experts. These sessions explored evolving global ...
Xinhua Silk Road: China (Chongqing)-UAE Economic and Trade Investment Promotion Conference Convened in Chongqing
CHONGQING, China, May 24, 2025 /PRNewswire/ -- The China (Chongqing)-UAE Economic and Trade Investment Promotion Conference, themed "Shared Vision, Shared Future," convened inChongqing, bringing together over 400 delegates from government, industry, and academia. The event was co-hosted by the Ch...
Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths
* YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] * Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeabilit...
Global Times: Why China's economy so stable despite external challenges?
BEIJING, May 23, 2025 /PRNewswire/ -- "In April, China's economic data showed resilience despite intensifying external challenges, especially as the exports expanded rapidly. Why is the economy so stable amid external challenges?" This is a question that a reader of people.cn posted. On May 19, ...
/DISREGARD RELEASE: Celltrion/
We are advised by Celltrion that journalists and other readers should disregard the news release, Celltrion's YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths, issued21-May-2025 over PR Newswire. ...
LILYSILK Unveils Breathable, Stretchable, and Machine-Washable Silk Jersey Collection for Summer 2025
NEW YORK, May 23, 2025 /PRNewswire/ -- LILYSILK
Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting
SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, including phase Ib/II clini...
41st WHO Sasakawa Health Prize Awarded to Denmark's Dr. Merete Nordentoft For Work on Suicide Prevention in Young People
TOKYO, May 23, 2025 /PRNewswire/ -- The 41st WHO Sasakawa Health Prize was
presented to Danish psychiatrist Dr.Merete Nordentoft in recognition of her
work on suicide prevention in young people, during a ceremony at the 78th World
Health Assembly inGeneva on May 23.
WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development
LANGFANG, China, May 23, 2025 /PRNewswire/ -- From May 19 to 23, 2025, the 29th World Gas Conference (WGC2025), hosted by the International Gas Union (IGU), convened inBeijing. As the premier global event in the energy sector, WGC2025 attracted leading companies and industry experts from around t...
UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study
SHANGHAI, May 23, 2025 /PRNewswire/ -- Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first administration of its proprietary Parkinson's disease cell drug UX-DA001 inChina in March 2025. The Phase I c...
Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing
HONG KONG, May 23, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason
Technology" or the "Company") (NYSE:DXF
Tuniu Announces Receipt of Minimum Bid Price Notice from Nasdaq
NANJING, China, May 23, 2025 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market L...
MINISO Group Announces March Quarter 2025 Unaudited Financial Results
Revenue grew 18.9 % year over year Significant sequential improvement of same-store sales(1) in MINISO mainland China for March Quarter Gross margin reached 44.2%, up 0.8 ppt year over year Adjusted EBITDA increased 7.5% year over year to RMB1,037.3 million Shareholder returns reached around RM...
Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030
* The global sporting goods industry launched the first-ever Sporting Goods
Physical Activity Impact Report: Moving the World Toward an Active Future
New Visions for the Future: 4th China-CEEC Expo & International Consumer Goods Fair Kicks Off
NINGBO, China, May 23, 2025 /PRNewswire/ -- A news report from Ningbo External Communication Center: On May 22, the 4th China-Central and Eastern European Countries (CEEC) Expo & International Consumer Goods Fair opened inNingbo, Zhejiang Province. With the theme "New Visions for the Future," th...
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting
CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), today announced that its collaborator, Pfizer, will present an abstract detailing the first-in-human Phase 1 clinical study design of MesoC...
SUNMI Opens Its First North American Store in Atlanta
ATLANTA, May 22, 2025 /PRNewswire/ -- On May 22, 2025, SUNMI, a global leader in smart business IoT solutions, celebrated the grand opening of its first North American store inAtlanta's central business district, unveiling the upgraded digital transformation experience space "SUNMI Home 2.0." The...
FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, to...
CARsgen's Satri-cel Abstract Available on ASCO Website
SHANGHAI, May 22, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that an abstract of the research results of the confirmatory Phase II clinical trial of satricabtagene autoleucel ("satri-...
Week's Top Stories
Most Reposted
Visa redefines its role in travel with the global expansion of Visa Destinations
[Picked up by 336 media titles]
2026-06-30 10:00Sustainable Tourism Academy Celebrates 3,000-User Milestone in First Year with ASEAN Expansion and New Language Support
[Picked up by 323 media titles]
2026-06-29 12:41Agoda rolls out suite of new features focused on real-time updates and smarter trip planning
[Picked up by 321 media titles]
2026-07-01 10:00On-us Brings Real-Time Smart E-Vouchers to Google Wallet, Giving Marketers a Live Read on Customer Behavior
[Picked up by 319 media titles]
2026-06-30 11:00Avnet Brings Ecosystem Together to Scale Edge AI in Singapore
[Picked up by 305 media titles]
2026-06-30 09:00